Jolley Asset Management, LLC
Filing Date
Mar 31, 2020
Global Rank
#3,148
/ 5,298
Top Industry
Drug Manufacturers - General
13.2%
3Y Alpha vs SPY
-3.3%
Period ended 6 years ago
Filed Apr 15, 2020 · 6y
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+61.2%
SPY
+74.2%
Annualised alpha
-3.1%
Max drawdown
−13.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
56 positions · as of Mar 31, 2020Top Position
4.7%
of portfolio value
Top 5
21.3%
of portfolio value
Top 10
40.9%
of portfolio value
HHI
309
Diversified
Sector Breakdown
As of Mar 31, 2020| Sector | % Portfolio | Value |
|---|---|---|
| Financial Services | 27.3% | $26,775,666 |
| Healthcare | 19.4% | $19,075,699 |
| Technology | 15.8% | $15,493,511 |
| Communication Services | 10.3% | $10,135,365 |
| Consumer Defensive | 8.6% | $8,466,050 |
| Industrials | 4.7% | $4,616,660 |
| Utilities | 4.1% | $4,004,162 |
| Energy | 3.5% | $3,409,147 |
| Consumer Cyclical | 3.3% | $3,283,972 |
| Basic Materials | 2.6% | $2,595,862 |
| Real Estate | 0.3% | $274,271 |
6 positions ·
$19,075,699 total
· Healthcare only
· as of Mar 31, 2020
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MRK |
Merck & Co., Inc.
Healthcare
|
First | 55,335 | $4,062,474 | 21.30% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
First | 68,038 | $4,036,694 | 21.16% | |
| PFE |
Pfizer Inc
Healthcare
|
First | 125,898 | $3,898,771 | 20.44% | |
| NVS |
Novartis AG
Healthcare
|
First | 46,955 | $3,871,439 | 20.30% | |
| ABT |
Abbott Laboratories
Healthcare
|
First | 26,113 | $2,060,576 | 10.80% | |
| ABBV |
AbbVie Inc.
Healthcare
|
First | 15,038 | $1,145,745 | 6.01% |